中国药品集中招标采购历程的文献研究:1999—2010  

The literature research of the drug centralized bidding and purchasing system in China from 1999 to 2010

作　　者：何芬华[1] 力晓蓉[2] 

机构地区：[1]成都中医药大学,四川成都610075 [2]四川省医学情报研究所,四川成都610075

出　　处：《中国卫生政策研究》2011年第4期64-70,共7页Chinese Journal of Health Policy

摘　　要：目的:分析我国药品集中招标采购的历程、问题及策略。方法:根据检索策略搜索文献,然后按照纳入排除标准筛选文献,并用文献定量分类表提取相关信息进行描述性统计分析。结果:学者对药品集中招标采购的关注度随着各个时期政策不同而有所变化;药品集中招标采购自实施的十余年来在招标主体、招标行为、招标范围等方面存在着许多问题。结论:药品集中采购制度是市场经济体制和国际惯例的客观要求,是我国医药卫生体制改革中不可或缺的、必须遵守的一项重要制度;我国药品集中采购工作历程短、模式多、操作复杂,需综合各项配套政策不断完善;药品集中采购的功能不是万能的,医药卫生体制改革才是解决问题的核心。Objective ： To analyze the problems and summarize useful strategies of the drug centralized bidding and purchasing system in China. Methods： This literature research searched for literatures using the search strategy and screened literatures according to inclusion and excluding criteria. Useful information in the literatures was extracted through quantitative analysis of literature tables and descriptive statistical analysis. Results： The scholars＇ concern towards bidding and purchasing in drugs were changing with the development of policy in different periods. Besides that, with the implementation of the drug centralized bidding and purchasing system, many problems had been aroused in different aspects such as the tender, bid activities and the scope of bidding. Conclusions： As a market economy and international requirement, centralized bidding and purchasing system is indispensable for our medical and health care reform, and more related policy or regulation should be added in the future for the reason of varied patterns, complex operation as well as lacking experience in the process. However, the drug centralized bidding and purchasing does not mean everything as the medical reforming is the core of the problem solving.

关 键 词：药品招标 集中采购 文献研究 

分 类 号：R951[医药卫生—药学]